Orion Infusions (DHA:ORIONINFU) YoY EBITDA Growth : 11.44% (As of Dec. 2024)

View and export this data going back to . Start your Free Trial

What is Orion Infusions YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Orion Infusions's YoY EBITDA Growth for the quarter that ended in Dec. 2024 was 11.44%.

Orion Infusions's EBITDA per Share for the three months ended in Dec. 2024 was BDT1.40.

Orion Infusions YoY EBITDA Growth Historical Data

The historical data trend for Orion Infusions's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orion Infusions YoY EBITDA Growth Chart

Orion Infusions Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

YoY EBITDA Growth

Get a 7-Day Free Trial

6.05

15.76

13.05

-9.00

3.64

Orion Infusions Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
YoY EBITDA Growth	Get a 7-Day Free Trial															7.70	15.38	-10.26	-6.57	11.44

Orion Infusions YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Orion Infusions's YoY EBITDA Growth for the fiscal year that ended in Jun. 2024 is calculated as:

	YoY EBITDA Growth (A: Jun. 2024 )
=	(EBITDA per Share (A: Jun. 2024 )	-	EBITDA per Share (A: Jun. 2023 ))	/	\| EBITDA per Share (A: Jun. 2023 ) \|
=	(5.326	-	5.139)	/	\| 5.139 \|
=	3.64 %

Orion Infusions's YoY EBITDA Growth for the quarter that ended in Dec. 2024 is calculated as:

	YoY EBITDA Growth (Q: Dec. 2024 )
=	(EBITDA per Share (Q: Dec. 2024 )	-	EBITDA per Share (Q: Dec. 2023 ))	/	\| EBITDA per Share (Q: Dec. 2023 )) \|
=	(1.403	-	1.259)	/	\| 1.259 \|
=	11.44 %

Orion Infusions YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Orion Infusions's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Orion Infusions Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orion Infusions Ltd (DHA:ORIONINFU) » Definitions » YoY EBITDA Growth

Traded in Other Exchanges

N/A

Address

153-154 Tejgaon I/A, Orion House, Dhaka, BGD, 1208

Website

https://www.orioninfusion.com

Orion Infusions Ltd is a pharmaceutical company. It produces various types of intravenous fluids, rehydration solutions, electrolyte solutions, antimicrobial products, and other pharmaceutical products in Bangladesh. The products of the company include Dextrolac, Dextropac, Dextrosal, Dianak, Electro dex, fructose, Hartman, Intralipid, Manisol, Maprocin, Nidazyl, Orlev, Ortac, Plasmasol, Proliv, and Salpac. In addition, the company is also involved in activities related to cosmetics and toiletries, infrastructure development, real estate and construction, power, agro products, hospitality, textiles and garments, and aviation management sectors. Geographically, it operates in Bangladesh.

Orion Infusions Headlines

No Headlines